{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:00:39Z","timestamp":1791385239993,"version":"4.3.3"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12DA000167"],"award-info":[{"award-number":["K12DA000167"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA243910"],"award-info":[{"award-number":["R01CA243910"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.cct.2021.106379","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T20:42:29Z","timestamp":1617050549000},"page":"106379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["A SMARTTT approach to Treating Tobacco use disorder in persons with HIV (SMARTTT): Rationale and design for a hybrid type 1 effectiveness-implementation study"],"prefix":"10.1016","volume":"110","author":[{"given":"E. Jennifer","family":"Edelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dziura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krysten W.","family":"Bold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M.","family":"Sigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Yager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Ledgerwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cct.2021.106379_bb0005","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cct.2021.106379_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(17)30170-5","article-title":"Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries","volume":"5","author":"Mdege","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.cct.2021.106379_bb0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ypmed.2018.03.007","article-title":"Trends in cigarette smoking among adults with HIV compared with the general adult population, United States - 2009-2014","volume":"111","author":"Frazier","year":"2018","journal-title":"Prev. Med."},{"issue":"5","key":"10.1016\/j.cct.2021.106379_bb0020","doi-asserted-by":"crossref","first-page":"e97698","DOI":"10.1371\/journal.pone.0097698","article-title":"Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study","volume":"9","author":"Valiathan","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cct.2021.106379_bb0025","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/0956462416632428","article-title":"Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis","volume":"28","author":"Farahani","year":"2017","journal-title":"Int. J. STD AIDS"},{"issue":"5","key":"10.1016\/j.cct.2021.106379_bb0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/cis933","article-title":"Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study","volume":"56","author":"Helleberg","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cct.2021.106379_bb0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QAD.0000000000000540","article-title":"Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America","volume":"29","author":"Helleberg","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.cct.2021.106379_bb0040","series-title":"Smoking and HIV","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"10.1016\/j.cct.2021.106379_bb0045","series-title":"Recommended Treatment Strategies for Clinicians Managing Older Patients with HIV","author":"Project THaAC","year":"2017"},{"key":"10.1016\/j.cct.2021.106379_bb0050","series-title":"HIV Provider Smoking Cessation Handbook","author":"HIV and Smoking Cessation Working Group VACPH","year":"2021"},{"key":"10.1016\/j.cct.2021.106379_bb0055","series-title":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV","author":"Department of Health and Human Services","year":"2019"},{"key":"10.1016\/j.cct.2021.106379_bb0060","article-title":"Interventions for tobacco use cessation in people living with HIV and AIDS","volume":"6","author":"Pool","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.cct.2021.106379_bb0065","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/ntr\/ntw126","article-title":"Smoking cessation for people living with HIV\/AIDS: a literature review and synthesis","volume":"18","author":"Ledgerwood","year":"2016","journal-title":"Nicotine Tob. Res."},{"issue":"3","key":"10.1016\/j.cct.2021.106379_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(18)30002-X","article-title":"Group AI-as. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 inter-ACTIV): a randomised controlled phase 3 clinical trial","volume":"5","author":"Mercie","year":"2018","journal-title":"Lancet HIV."},{"issue":"1","key":"10.1016\/j.cct.2021.106379_bb0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/ntr\/nts121","article-title":"Safety of varenicline among smokers enrolled in the lung HIV study","volume":"15","author":"Ferketich","year":"2013","journal-title":"Nicotine Tob. Res."},{"issue":"1","key":"10.1016\/j.cct.2021.106379_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/apc.2011.0199","article-title":"Safety and tolerability of varenicline tartrate (Champix((R))\/Chantix((R))) for smoking cessation in HIV-infected subjects: a pilot open-label study","volume":"26","author":"Cui","year":"2012","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.cct.2021.106379_bb0085","author":"NIH Research Portfoli Online Reporting Tools (RePORT)"},{"issue":"7","key":"10.1016\/j.cct.2021.106379_bb0090","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1592\/phco.27.7.1040","article-title":"Tobacco interventions delivered by pharmacists: a summary and systematic review","volume":"27","author":"Dent","year":"2007","journal-title":"Pharmacotherapy."},{"issue":"3","key":"10.1016\/j.cct.2021.106379_bb0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jcpt.12131","article-title":"Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy","volume":"39","author":"Saba","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.cct.2021.106379_bb0100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/1524839913509816","article-title":"Comparison of an intensive pharmacist-managed telephone clinic with standard of care for tobacco cessation in a veteran population","volume":"15","author":"Chen","year":"2014","journal-title":"Health Promot. Pract."},{"key":"10.1016\/j.cct.2021.106379_bb0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/PPA.S30244","article-title":"The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review","volume":"6","author":"Saberi","year":"2012","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1016\/j.cct.2021.106379_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/09540121.2017.1344350","article-title":"Integrating cardiovascular diseases, hypertension, and diabetes with HIV services: a systematic review","volume":"30","author":"Haldane","year":"2018","journal-title":"AIDS Care"},{"issue":"12","key":"10.1016\/j.cct.2021.106379_bb0115","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/phar.2043","article-title":"A pharmacist-led program to evaluate and reduce polypharmacy and potentially inappropriate prescribing in older HIV-positive patients","volume":"37","author":"McNicholl","year":"2017","journal-title":"Pharmacotherapy."},{"issue":"1","key":"10.1016\/j.cct.2021.106379_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/her\/cyw051","article-title":"Step care treatment for smoking cessation","volume":"32","author":"Ebbert","year":"2017","journal-title":"Health Educ. Res."},{"key":"10.1016\/j.cct.2021.106379_bb0125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cct.2017.07.002","article-title":"Program for lung cancer screening and tobacco cessation: Study protocol of a sequential, multiple assignment, randomized trial","volume":"60","author":"Fu","year":"2017","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"10.1016\/j.cct.2021.106379_bb0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cct.2012.11.008","article-title":"Stepped care to optimize pain care effectiveness (SCOPE) trial study design and sample characteristics","volume":"34","author":"Kroenke","year":"2013","journal-title":"Contemp Clin Trials."},{"issue":"2","key":"10.1016\/j.cct.2021.106379_bb0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1017\/S0033291714000701","article-title":"Stepped care treatment delivery for depression: a systematic review and meta-analysis","volume":"45","author":"van Straten","year":"2015","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.cct.2021.106379_bb0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1037\/0022-006X.68.4.573","article-title":"Stepped care as a heuristic approach to the treatment of alcohol problems","volume":"68","author":"Sobell","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.cct.2021.106379_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-015-0048-z","article-title":"Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics","volume":"11","author":"Edelman","year":"2016","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.cct.2021.106379_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cct.2016.11.008","article-title":"The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients","volume":"52","author":"Edelman","year":"2017","journal-title":"Contemp Clin Trials"},{"issue":"8","key":"10.1016\/j.cct.2021.106379_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(19)30076-1","article-title":"Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial","volume":"6","author":"Edelman","year":"2019","journal-title":"Lancet HIV."},{"key":"10.1016\/j.cct.2021.106379_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jsat.2019.08.007","article-title":"Integrated stepped alcohol treatment for patients with HIV and liver disease: a randomized trial","volume":"106","author":"Edelman","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"issue":"4","key":"10.1016\/j.cct.2021.106379_bb0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11904-012-0138-4","article-title":"Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals","volume":"9","author":"Niaura","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"8","key":"10.1016\/j.cct.2021.106379_bb0170","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/09540121.2010.542128","article-title":"Recent cigarette smoking and HIV disease progression: no evidence of an association","volume":"23","author":"Kabali","year":"2011","journal-title":"AIDS Care"},{"issue":"6","key":"10.1016\/j.cct.2021.106379_bb0175","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1007\/s10461-017-1928-x","article-title":"Baseline cigarette smoking status as a predictor of virologic suppression and cd4 cell count during one-year follow-up in substance users with uncontrolled HIV infection","volume":"22","author":"Winhusen","year":"2018","journal-title":"AIDS Behav."},{"issue":"6","key":"10.1016\/j.cct.2021.106379_bb0180","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s10461-017-1915-2","article-title":"Adolescent medicine trials network for HIVAI, tobacco use and sustained viral suppression in youth living with HIV","volume":"22","author":"Gamarel","year":"2018","journal-title":"AIDS Behav."},{"issue":"7","key":"10.1016\/j.cct.2021.106379_bb0185","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/cir989","article-title":"Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?","volume":"54","author":"Justice","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cct.2021.106379_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/QAI.0b013e31827df36c","article-title":"Predictive accuracy of the veterans aging cohort study index for mortality with hiv infection: a north american cross cohort analysis","volume":"62","author":"Justice","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.cct.2021.106379_bb0195","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/QAI.0000000000000045","article-title":"Infectious Disease Clinical Research Program HIVWG, The VACS index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy","volume":"65","author":"Bebu","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.cct.2021.106379_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2016.01.017","article-title":"Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men","volume":"161","author":"Justice","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.cct.2021.106379_bb0205","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/QAD.0000000000001473","article-title":"Long-term alcohol use patterns and HIV disease severity","volume":"31","author":"Marshall","year":"2017","journal-title":"AIDS."},{"key":"10.1016\/j.cct.2021.106379_bb0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drugalcdep.2018.04.022","article-title":"Changes in alcohol use associated with changes in HIV disease severity over time: a national longitudinal study in the veterans aging cohort","volume":"189","author":"Williams","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.cct.2021.106379_bb0215","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/QAD.0000000000002140","article-title":"Veterans aging cohort S, the antiretroviral therapy cohort C. albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals","volume":"33","author":"Tate","year":"2019","journal-title":"AIDS."},{"key":"10.1016\/j.cct.2021.106379_bb0220","author":"Lei"},{"key":"10.1016\/j.cct.2021.106379_bb0225","author":"National Cancer Institute"},{"issue":"3","key":"10.1016\/j.cct.2021.106379_bb0230","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/08897077.2016.1154494","article-title":"Concordance between timeline follow-back and single-question assessment of self-reported smoking in a clinical trial","volume":"37","author":"Bernstein","year":"2016","journal-title":"Subst. Abus."},{"issue":"3","key":"10.1016\/j.cct.2021.106379_bb0235","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1360-0443.2004.00995.x","article-title":"Outcome criteria in smoking cessation trials: proposal for a common standard","volume":"100","author":"West","year":"2005","journal-title":"Addiction."},{"issue":"7","key":"10.1016\/j.cct.2021.106379_bb0240","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/ntr\/ntz132","article-title":"Biochemical verification of tobacco use and abstinence: 2019 update","volume":"22","author":"Benowitz","year":"2020","journal-title":"Nicotine Tob. Res."},{"issue":"7","key":"10.1016\/j.cct.2021.106379_bb0245","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ntr\/ntz110","article-title":"Defining and measuring abstinence in clinical trials of smoking cessation interventions: an updated review","volume":"22","author":"Piper","year":"2020","journal-title":"Nicotine Tob. Res."},{"issue":"3","key":"10.1016\/j.cct.2021.106379_bb0250","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med. Care"},{"key":"10.1016\/j.cct.2021.106379_bb0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1940-0640-9-12","article-title":"An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers","volume":"9","author":"Hagedorn","year":"2014","journal-title":"Addict Sci Clin Pract"},{"issue":"10","key":"10.1016\/j.cct.2021.106379_bb0260","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/sim.2022","article-title":"An experimental design for the development of adaptive treatment strategies","volume":"24","author":"Murphy","year":"2005","journal-title":"Stat. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.cct.2021.106379_bb0265","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.drugalcdep.2007.02.001","article-title":"Customizing treatment to the patient: adaptive treatment strategies","volume":"88","author":"Murphy","year":"2007","journal-title":"Drug Alcohol Depend."},{"issue":"5 Suppl","key":"10.1016\/j.cct.2021.106379_bb0270","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.amepre.2007.01.022","article-title":"The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions","volume":"32","author":"Collins","year":"2007","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.cct.2021.106379_bb0275","article-title":"Nicotine replacement therapy for smoking cessation","volume":"11","author":"Stead","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cct.2021.106379_bb0280","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"5","author":"Cahill","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.cct.2021.106379_bb0285","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/add.12589","article-title":"Prize-based contingency management for the treatment of substance abusers: a meta-analysis","volume":"109","author":"Benishek","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2021.106379_bb0290","article-title":"Incentives for smoking cessation","volume":"5","author":"Cahill","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.cct.2021.106379_bb0295","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10461-011-9891-4","article-title":"Provider beliefs and practices relating to tobacco use in patients living with HIV\/AIDS: a national survey","volume":"16","author":"Shuter","year":"2012","journal-title":"AIDS Behav."},{"issue":"5 Suppl 3","key":"10.1016\/j.cct.2021.106379_bb0300","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1016\/j.amepre.2012.07.032","article-title":"Addressing smoking during medical visits: patients with human immunodeficiency virus","volume":"43","author":"Horvath","year":"2012","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.cct.2021.106379_bb5000","article-title":"Readiness to provide medications for opioid, alcohol and tobacco use disorder in HIV clinics: A multi-site mixed-methods formative evaluation","author":"Jennifer Edelman","year":"2021","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.cct.2021.106379_bb0305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2146\/ajhp160322","article-title":"Incorporating a pharmacist into an interprofessional team providing transgender care under a medical home model","volume":"74","author":"Newsome","year":"2017","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.cct.2021.106379_bb0310","series-title":"Care Action. Pharmacists: Prescribing Better Care","author":"HRSA","year":"2010"},{"issue":"6","key":"10.1016\/j.cct.2021.106379_bb0315","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.2105\/AJPH.2013.301299","article-title":"The RE-AIM framework: a systematic review of use over time","volume":"103","author":"Gaglio","year":"2013","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.cct.2021.106379_bb0320","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0738-3991(00)00186-5","article-title":"The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management?","volume":"44","author":"Glasgow","year":"2001","journal-title":"Patient Educ. Couns."},{"issue":"9","key":"10.1016\/j.cct.2021.106379_bb0325","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am. J. Public Health"},{"issue":"1","key":"10.1016\/j.cct.2021.106379_bb0330","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13012-016-0398-2","article-title":"PARIHS revisited: from heuristic to integrated framework for the successful implementation of knowledge into practice","volume":"11","author":"Harvey","year":"2016","journal-title":"Implement. Sci."},{"key":"10.1016\/j.cct.2021.106379_bb0335","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1748-5908-6-99","article-title":"A Guide for applying a revised version of the PARIHS framework for implementation","volume":"6","author":"Stetler","year":"2011","journal-title":"Implement. Sci."},{"key":"10.1016\/j.cct.2021.106379_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-3-1","article-title":"Evaluating the successful implementation of evidence into practice using the PARiHS framework: theoretical and practical challenges","volume":"3","author":"Kitson","year":"2008","journal-title":"Implement. Sci."},{"issue":"8","key":"10.1016\/j.cct.2021.106379_bb0345","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1037\/adb0000287","article-title":"Contingency management treatment for substance use disorders: How far has it come, and where does it need to go?","volume":"31","author":"Petry","year":"2017","journal-title":"Psychol. Addict. Behav."},{"issue":"4","key":"10.1016\/j.cct.2021.106379_bb0350","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11904-015-0281-9","article-title":"Tobacco use, use disorders, and smoking cessation interventions in persons living with HIV","volume":"12","author":"Pacek","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.cct.2021.106379_bb0355","series-title":"Inter-university Consortium for Political and Social Research [distributor]","author":"Hesse","year":"2007"},{"key":"10.1016\/j.cct.2021.106379_bb0360","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"Measuring the heaviness of smoking using self-reported time to first cigarette of the day and number of cigarettes smoked per day","volume":"86","author":"Heatherton","year":"1989","journal-title":"Brit J Addiction."},{"key":"10.1016\/j.cct.2021.106379_bb0365","series-title":"Treating Tobacco Use and Dependence: 2008 Update","author":"Fiore","year":"2008"},{"key":"10.1016\/j.cct.2021.106379_bb0370","author":"American Lung Association"},{"issue":"8","key":"10.1016\/j.cct.2021.106379_bb0375","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40266-013-0093-9","article-title":"The next therapeutic challenge in HIV: polypharmacy","volume":"30","author":"Edelman","year":"2013","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.cct.2021.106379_bb0380","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/QAD.0000000000001756","article-title":"Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals","volume":"32","author":"Justice","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.cct.2021.106379_bb0385","author":"American Academy of Family Physicians"},{"key":"10.1016\/j.cct.2021.106379_bb0390","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jsat.2016.06.009","article-title":"Contingency management interventions for HIV, tuberculosis, and hepatitis control among individuals with substance use disorders: a systematized review","volume":"72","author":"Herrmann","year":"2017","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2021.106379_bb0395","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ypmed.2016.08.008","article-title":"A review of the literature on contingency management in the treatment of substance use disorders, 2009\u20132014","volume":"92","author":"Davis","year":"2016","journal-title":"Prev. Med."},{"issue":"7","key":"10.1016\/j.cct.2021.106379_bb0400","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/apc.2018.0014","article-title":"Enhancing patient navigation with contingent incentives to improve healthcare behaviors and viral load suppression of persons with HIV and substance use","volume":"32","author":"Stitzer","year":"2018","journal-title":"AIDS Patient Care STDs"},{"issue":"1","key":"10.1016\/j.cct.2021.106379_bb0405","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugalcdep.2006.09.019","article-title":"Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial","volume":"88","author":"Sorensen","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2021.106379_bb0410","series-title":"Contingency Management for Substance Abuse Treatment: A Guide to Implementing this Evidence-Based Practice New York","author":"Petry","year":"2012"},{"key":"10.1016\/j.cct.2021.106379_bb0415","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.drugalcdep.2014.03.032","article-title":"Prize contingency management for smoking cessation: a randomized trial","volume":"140","author":"Ledgerwood","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2021.106379_bb0420","series-title":"Yale University Psychotherapy Development Center Training Series No 6","article-title":"Contingency management: Using motivational incentives to improve drug abuse treatment","author":"Petry","year":"2021"},{"issue":"1\u20133","key":"10.1016\/j.cct.2021.106379_bb0425","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2009.12.027","article-title":"Psychometric properties of the contingency management competence scale","volume":"109","author":"Petry","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2021.106379_bb0430","first-page":"1119","article-title":"The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Addiction."},{"issue":"4","key":"10.1016\/j.cct.2021.106379_bb0435","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/QAI.0000000000002049","article-title":"HIV disease severity is sensitive to temporal changes in alcohol use: a national study of VA patients with HIV","volume":"81","author":"Williams","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.cct.2021.106379_bb0440","doi-asserted-by":"crossref","first-page":"107511","DOI":"10.1016\/j.drugalcdep.2019.06.014","article-title":"Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment","volume":"204","author":"McGinnis","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2021.106379_bb0445","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0895-4356(01)00449-8","article-title":"Development and validation of a self-completed HIV symptom index","volume":"54","author":"Justice","year":"2001","journal-title":"J. Clin. Epidemiol."},{"issue":"7","key":"10.1016\/j.cct.2021.106379_bb0450","doi-asserted-by":"crossref","first-page":"e0201093","DOI":"10.1371\/journal.pone.0201093","article-title":"Cross-sectional validation of the PROMIS-Preference scoring system","volume":"13","author":"Hanmer","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cct.2021.106379_bb0455","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00005053-199202000-00007","article-title":"A new measure of substance abuse treatment. Initial studies of the treatment services review","volume":"180","author":"McLellan","year":"1992","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.cct.2021.106379_bb0460","series-title":"Interventions for tobacco use cessation in people living with HIV and AIDS","author":"Pool","year":"2016"},{"key":"10.1016\/j.cct.2021.106379_bb0465","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/1462220031000070552","article-title":"Measures of abstinence in clinical trials: issues and recommendations","volume":"5","author":"Hughes","year":"2003","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.cct.2021.106379_bb0470","series-title":"Statistical Methodology for a SMART Design in the Development of Adaptive Treatment Strategies. (Tech. Rep. No. 07\u201382)","author":"Crivello","year":"2007"},{"key":"10.1016\/j.cct.2021.106379_bb0475","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1748-5908-5-82","article-title":"A critical synthesis of literature on the promoting action on research implementation in health services (PARIHS) framework","volume":"5","author":"Helfrich","year":"2010","journal-title":"Implement. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2021.106379_bb0480","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1097\/QAI.0b013e31820a9a82","article-title":"Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings","volume":"56","author":"Lum","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"4","key":"10.1016\/j.cct.2021.106379_bb0485","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/09540121.2018.1500007","article-title":"Addressing smoking among people living with HIV: a cross-sectional survey of Australian HIV health practitioners' practices and attitudes","volume":"31","author":"Bell","year":"2019","journal-title":"AIDS Care"},{"issue":"5","key":"10.1016\/j.cct.2021.106379_bb0490","doi-asserted-by":"crossref","first-page":"e204561","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.cct.2021.106379_bb0495","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugalcdep.2011.08.027","article-title":"Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire","volume":"121","author":"Rash","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2021.106379_bb0500","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1748-5908-9-7","article-title":"Organizational readiness for implementing change: a psychometric assessment of a new measure","volume":"9","author":"Shea","year":"2014","journal-title":"Implement. Sci."},{"key":"10.1016\/j.cct.2021.106379_bb0505","author":"NIH Research Portfolio Online Reporting Tools (RePORT)"},{"key":"10.1016\/j.cct.2021.106379_bb0510","author":"ClinicalTrials.gov"},{"key":"10.1016\/j.cct.2021.106379_bb0515","article-title":"Integration of care for HIV and opioid use disorder: a systematic review of interventions in clinical and community-based settings","author":"Oldfield","year":"2018","journal-title":"AIDS."},{"issue":"7","key":"10.1016\/j.cct.2021.106379_bb0520","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s10461-020-02926-x","article-title":"COVID-19 telemedicine, and patient empowerment in HIV care and research","volume":"24","author":"Mgbako","year":"2020","journal-title":"AIDS Behav."},{"issue":"2","key":"10.1016\/j.cct.2021.106379_bb0525","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/art.10993","article-title":"The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research","volume":"49","author":"Sangha","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"16","key":"10.1016\/j.cct.2021.106379_bb0530","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol use disorders identification test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch. Intern. Med."},{"issue":"1\u20132","key":"10.1016\/j.cct.2021.106379_bb0535","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugalcdep.2013.03.001","article-title":"Ultra-rapid screening for substance-use disorders: the alcohol, smoking and substance involvement screening test (ASSIST-lite)","volume":"132","author":"Ali","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.cct.2021.106379_bb0540","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.cct.2021.106379_bb0545","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med. Care"},{"issue":"9","key":"10.1016\/j.cct.2021.106379_bb0550","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.addbeh.2014.02.013","article-title":"Examination of a short English version of the UPPS-P Impulsive Behavior Scale","volume":"39","author":"Cyders","year":"2014","journal-title":"Addict. Behav."},{"key":"10.1016\/j.cct.2021.106379_bb0555","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.cct.2021.106379_bb0560","series-title":"The Wisconsin Predicting Patients' Relapse (WI-PREPARE) Questionnaire","author":"Bolt","year":"2008"},{"issue":"6","key":"10.1016\/j.cct.2021.106379_bb0565","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/apc.2012.0044","article-title":"Patient-reported symptoms on the antiretroviral regimen efavirenz\/emtricitabine\/tenofovir","volume":"26","author":"Edelman","year":"2012","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"10.1016\/j.cct.2021.106379_bb0570","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10461-010-9706-z","article-title":"Patient and provider-reported symptoms in the post-cART era","volume":"15","author":"Edelman","year":"2011","journal-title":"AIDS Behav."},{"issue":"2","key":"10.1016\/j.cct.2021.106379_bb0580","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11606-006-0050-y","article-title":"Patient satisfaction with primary care office-based buprenorphine\/naloxone treatment","volume":"22","author":"Barry","year":"2007","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cct.2021.106379_bb0585","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pmedr.2017.02.012","article-title":"Disparities in receipt of 5As for smoking cessation in diverse primary care and HIV clinics","volume":"6","author":"Vijayaraghavan","year":"2017","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.cct.2021.106379_bb0590","doi-asserted-by":"crossref","first-page":"106156","DOI":"10.1016\/j.cct.2020.106156","article-title":"Working with HIV clinics to adopt addiction treatment using implementation facilitation (WHAT-IF?): Rationale and design for a hybrid type 3 effectiveness-implementation study","volume":"98","author":"Edelman","year":"2020","journal-title":"Contemp Clin Trials"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714421001154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714421001154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:56:26Z","timestamp":1761555386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714421001154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":118,"alternative-id":["S1551714421001154"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2021.106379","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A SMARTTT approach to Treating Tobacco use disorder in persons with HIV (SMARTTT): Rationale and design for a hybrid type 1 effectiveness-implementation study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2021.106379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106379"}}